How Does Timing Impact Side Effects
(
Monitoring and Kidney-Safe Dosing During GLP-1 Therapy Transplant recipients beginning GLP-1 therapy should maintain baseline kidney lab workserum creatinine, GFR estimate, urinalysis, and spot urine protein-to-creatinine ratioprior to semaglutide initiation and at 3, 6, and 12 months
The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on Rybelsus
Gallup found that the use of these drugs specifically to lose weight (theyre also used to treat diabetes) has more than doubled from February 2024, when it was 5.8%, to 12.4% currently: More women (15.2%) are taking the drugs than men (9.7%), which correlates with a slightly larger decline in obesity rates among women
The company has started focusing more on providing access to brand-name and FDA-approved weight loss medications such as Wegovy and Zepbound through its WW Clinic